This article is published in association with United Nations. The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries. The spurious semaglutides – of a specific brand Ozempic […]UN health agency issues alert on falsified medicines used for diabetes treatment, weight loss
June 21, 2024 by Leave a Comment
This article is published in association with United Nations. The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries. The spurious semaglutides – of a specific brand Ozempic […]Commission report finds active competition enforcement continues to contribute to affordable and innovative medicines
January 29, 2024 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission has published a report providing an overview of the enforcement of EU antitrust and merger rules by the Commission and the national competition authorities (‘NCAs’) in the pharmaceutical sector between 2018 and 2022. Today’s report shows that active enforcement of antitrust […]Commission publishes first Union Critical Medicines list to tackle shortages
December 13, 2023 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission has published today the first Union list of critical medicines, together with the European Medicines Agency (EMA) and the Member States’ Heads of Medicines Agencies (HMA). The publication follows the commitment made in the Commission’s Communication on addressing medicine shortages in […]European Health Union: Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines
April 27, 2023 by Leave a Comment
This article is brought to you in association with the European Commission. Today, the Commission is proposing to revise the EU’s pharmaceutical legislation – the largest reform in over 20 years – to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more […]EU-UK relations: Commission extends arrangements for veterinary medicines to 2025
December 20, 2022 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission has today adopted a notice which extends to 31 December 2025 the current arrangements for the movement of veterinary medicines from Great Britain to Cyprus, Ireland, Malta and Northern Ireland. This will ensure the continuity of supplies of veterinary medicinal products, […]Pfizer commits to providing patent-protected medicines in Africa
May 30, 2022 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Harry Gray Calvo, Media Relations and Public Affairs Specialist, World Economic Forum A high-level panel including Paul Kagame and Lazarus Chakwera, presidents of Rwanda and Malawi, and Bill Gates joined Pfizer in call to bridge global health equity […]Veterinary medicines: New rules to promote animal health and fight antimicrobial resistance now apply
January 31, 2022 by 2 Comments
This article is brought to you in association with the European Commission. In the fight against antimicrobial resistance (AMR), a revamped legislation on veterinary medicinal products applies in the EU as from today. Adopted three years ago, this legislation is now a cornerstone to support the achievement of the objectives set in the European One Health […]European Health Union: European Commission welcomes step towards better access to medicines and medical devices during crisis
June 15, 2021 by Leave a Comment
This article is brought to you in association with the European Commission. Today, the Council has adopted its position on the November 2020 Commission proposal to give the European Medicines Agency (EMA) a stronger role in crisis preparedness and management. This proposal would allow the EMA to facilitate activities such as monitoring and mitigating the risk […]Medicines from the sky: how drones can save lives
April 22, 2020 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Craig Kennedy, Senior Vice President, Global Supply Chain Management, Merck Sharp & Dohme From COVID-19 to cholera, health crises expose unequal access to care. With the right regulations and technology in place, drones could be used to deliver […]The blackened white coat of the doctors
June 21, 2019 by Leave a Comment
This article was exclusively written for The European Sting by Ms. Sahiba Maniar, a 6th Semester Medical student from India, who is extremely passionate about human rights. She is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not necessarily […]Medical training without borders: what’s still missing?
January 3, 2019 by Leave a Comment
This article was exclusively written for the The European Sting by Ms. Aurimarcia Torres, a second year medical student at the Federal University of Rio Grande do Norte in Natal, Brazil. She is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do […]MEPs back plans to boost joint assessment of medicines
October 4, 2018 by Leave a Comment
This article is brought to you in association with the European Parliament. The new law adopted on Wednesday aims to avoid duplicating national assessments to determine a medicine’s added value that help EU countries decide on pricing. MEPs highlight that there are many barriers to accessing medicine and innovative technologies in the EU, the main ones […]Health Committee MEPs back plans to boost joint assessment of medicines
September 17, 2018 by 1 Comment
This article is brought to you in association with the European Parliament. The new law aims to avoid duplicating national assessments to determine a medicine’s added value that help EU countries decide on pricing and reimbursement. MEPs highlight that there are many barriers to accessing medicine and innovative technologies in the EU, the main ones being […]
